welcome_1

Welcome to IMI 2016 “Novel approaches to fight bacteria”

Greetings from Mathias...

Greetings from Mathias…

welcome_3

… leading the way

Registration @ the welcome desk

Registration @ the welcome desk

Welcome to plenary talks

Welcome to plenary talks

Dirk Bumann (University of Basel, Basel, Germany) - What’s there: proteomic approach to understand the outer cell wall permeability

Dirk Bumann (University of Basel, Basel, Germany) – What’s there: proteomic approach to understand the outer cell wall permeability

Sabine Wronski (Fraunhofer ITEM, Hannover, Germany) - Preclinical efficacy and safety testing of antimicrobial compounds

Sabine Wronski (Fraunhofer ITEM, Hannover, Germany) – Preclinical efficacy and safety testing of antimicrobial compounds

A well deserved coffee break...

A well deserved coffee break…

... with coffee and cookies...

… with coffee and cookies…

... and poster discussions, of course,

… and poster discussions, of course,

poster_2

… in deepth

and parallel meetings

and parallel meetings

PneumoNP

PneumoNP

Nareb

Nareb

Hessel van der Weide (Erasmus Medical Centre, Rotterdam, The Netherlands) - Rat models of K. pneumoniae-ESBL and K. pneumoniae-KPC pneumonia, set-up and clinical validation

Hessel van der Weide (Erasmus Medical Centre, Rotterdam, The Netherlands) – Rat models of K. pneumoniae-ESBL and K. pneumoniae-KPC pneumonia, set-up and clinical validation

Jordi Llop (CIC BiomaGUNE, Donostia/San Sebastián, Spain) - Determination of regional distribution in the lungs using nuclear imaging

Jordi Llop (CIC BiomaGUNE, Donostia/San Sebastián, Spain) – Determination of regional distribution in the lungs using nuclear imaging

Magnus Strandh (Adenium Biotech, Copenhagen, Denmark) - Clinical development of antimicrobial peptides -opportunities and challenges from a SME perspective

Magnus Strandh (Adenium Biotech, Copenhagen, Denmark) – Clinical development of antimicrobial peptides -opportunities and challenges from a SME perspective

Malcolm Page (Jacobs University, Bremen, Germany) - What are the current bottlenecks in antibiotic research?

Malcolm Page (Jacobs University, Bremen, Germany) – What are the current bottlenecks in antibiotic research?

Robert Stavenger (GSK, Collegeville, USA) - Overview on the New drugs for bad bugs platform: Translocation & Enable

Robert Stavenger (GSK, Collegeville, USA) – Overview on the New drugs for bad bugs platform: Translocation & Enable

An evening BBQ...

An evening BBQ…

evening_2

evening_3

... with delicious desert...

… with delicious desert…

... and beer, of course,

… and beer, of course,

... to go with the game (UEFA euro 2016 final match)

… to go with the game (UEFA euro 2016 final match)…

evening_7

Goodbye...

Goodbye…